CGEM — Cullinan Oncology Balance Sheet
0.000.00%
Last trade - 00:00
- $714.03m
- $247.15m
- 30
- 27
- 93
- 48
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 98.6 | 210 | 290 | 467 | 467 |
Prepaid Expenses | |||||
Total Current Assets | 100 | 212 | 297 | 474 | 480 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.182 | 0.13 | 0.077 | 5.3 | 3.53 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 100 | 215 | 437 | 561 | 484 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.52 | 14.3 | 11.7 | 22.5 | 28.1 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.46 | 15.7 | 12.2 | 26.1 | 30.5 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 97 | 199 | 425 | 535 | 454 |
Total Liabilities & Shareholders' Equity | 100 | 215 | 437 | 561 | 484 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |